Insurance status correlation with advanced breast cancer presentation, delayed diagnosis, and treatment among the hispanic population

Research output: Contribution to journalArticle

Abstract

PURPOSE: Study the Insurance status of Breast Cancer patients and its relevance to delayed diagnosis and treatment. METHODS: To identify Breast Cancer patients, a search was completed using the Arizona Tumor Registry for years 1991-1996. Hispanic patients were identified using the Tumor Registry designation of ethnicity. The patient charts were reviewed and categorized for ethnicity, year of diagnosis, patient's age at diagnosis, cancer stage at diagnosis, and duration between time of diagnosis and treatment. Statistical analysis will link patient's insurance status with diagnosis and treatment. RESULTS: Of the 50 patients reviewed, 19 have met the study criteria. 10 had insurance at the time of diagnosis, while nine did not. The average age at the time of diagnosis was 52.47 years, with an average weight of 70.93 kg, and average height of 62.53 inches. The stages of the cancer when diagnosed were distributed as follows: stage 1; 6 patients, stage 2; 8 patients, stage 3; 2 patients. Tumor staging was has yet to be determined for 3 patients. Although the difference in cancer stage at time of diagnosis between insured and non-insured patients was insignificant, the time span between diagnosis and treatment of patients with insurance averaged 29.9 days, while the non-insured patients averaged 78.6 days. CONCLUSIONS: From past studies we do know that long-term survival of women with breast cancer is dependent on the stage of the disease at the time of diagnosis. It is also been shown that breast cancer diagnosis at early stages of progression is low in the Hispanic population compared to the white non-Hispanic population. We hope to identify further factors that are contributing to this difference.

Original languageEnglish (US)
JournalJournal of Investigative Medicine
Volume47
Issue number2
StatePublished - Feb 1999

Fingerprint

Insurance Coverage
Delayed Diagnosis
Insurance
Hispanic Americans
Breast Neoplasms
Population
Therapeutics
Tumors
Neoplasms
Registries
Neoplasm Staging
Statistical methods

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{9a974fade2474f3195f0c684b9c54b8b,
title = "Insurance status correlation with advanced breast cancer presentation, delayed diagnosis, and treatment among the hispanic population",
abstract = "PURPOSE: Study the Insurance status of Breast Cancer patients and its relevance to delayed diagnosis and treatment. METHODS: To identify Breast Cancer patients, a search was completed using the Arizona Tumor Registry for years 1991-1996. Hispanic patients were identified using the Tumor Registry designation of ethnicity. The patient charts were reviewed and categorized for ethnicity, year of diagnosis, patient's age at diagnosis, cancer stage at diagnosis, and duration between time of diagnosis and treatment. Statistical analysis will link patient's insurance status with diagnosis and treatment. RESULTS: Of the 50 patients reviewed, 19 have met the study criteria. 10 had insurance at the time of diagnosis, while nine did not. The average age at the time of diagnosis was 52.47 years, with an average weight of 70.93 kg, and average height of 62.53 inches. The stages of the cancer when diagnosed were distributed as follows: stage 1; 6 patients, stage 2; 8 patients, stage 3; 2 patients. Tumor staging was has yet to be determined for 3 patients. Although the difference in cancer stage at time of diagnosis between insured and non-insured patients was insignificant, the time span between diagnosis and treatment of patients with insurance averaged 29.9 days, while the non-insured patients averaged 78.6 days. CONCLUSIONS: From past studies we do know that long-term survival of women with breast cancer is dependent on the stage of the disease at the time of diagnosis. It is also been shown that breast cancer diagnosis at early stages of progression is low in the Hispanic population compared to the white non-Hispanic population. We hope to identify further factors that are contributing to this difference.",
author = "K. Stevens and Adamas-Rappaport, {William -}",
year = "1999",
month = "2",
language = "English (US)",
volume = "47",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Insurance status correlation with advanced breast cancer presentation, delayed diagnosis, and treatment among the hispanic population

AU - Stevens, K.

AU - Adamas-Rappaport, William -

PY - 1999/2

Y1 - 1999/2

N2 - PURPOSE: Study the Insurance status of Breast Cancer patients and its relevance to delayed diagnosis and treatment. METHODS: To identify Breast Cancer patients, a search was completed using the Arizona Tumor Registry for years 1991-1996. Hispanic patients were identified using the Tumor Registry designation of ethnicity. The patient charts were reviewed and categorized for ethnicity, year of diagnosis, patient's age at diagnosis, cancer stage at diagnosis, and duration between time of diagnosis and treatment. Statistical analysis will link patient's insurance status with diagnosis and treatment. RESULTS: Of the 50 patients reviewed, 19 have met the study criteria. 10 had insurance at the time of diagnosis, while nine did not. The average age at the time of diagnosis was 52.47 years, with an average weight of 70.93 kg, and average height of 62.53 inches. The stages of the cancer when diagnosed were distributed as follows: stage 1; 6 patients, stage 2; 8 patients, stage 3; 2 patients. Tumor staging was has yet to be determined for 3 patients. Although the difference in cancer stage at time of diagnosis between insured and non-insured patients was insignificant, the time span between diagnosis and treatment of patients with insurance averaged 29.9 days, while the non-insured patients averaged 78.6 days. CONCLUSIONS: From past studies we do know that long-term survival of women with breast cancer is dependent on the stage of the disease at the time of diagnosis. It is also been shown that breast cancer diagnosis at early stages of progression is low in the Hispanic population compared to the white non-Hispanic population. We hope to identify further factors that are contributing to this difference.

AB - PURPOSE: Study the Insurance status of Breast Cancer patients and its relevance to delayed diagnosis and treatment. METHODS: To identify Breast Cancer patients, a search was completed using the Arizona Tumor Registry for years 1991-1996. Hispanic patients were identified using the Tumor Registry designation of ethnicity. The patient charts were reviewed and categorized for ethnicity, year of diagnosis, patient's age at diagnosis, cancer stage at diagnosis, and duration between time of diagnosis and treatment. Statistical analysis will link patient's insurance status with diagnosis and treatment. RESULTS: Of the 50 patients reviewed, 19 have met the study criteria. 10 had insurance at the time of diagnosis, while nine did not. The average age at the time of diagnosis was 52.47 years, with an average weight of 70.93 kg, and average height of 62.53 inches. The stages of the cancer when diagnosed were distributed as follows: stage 1; 6 patients, stage 2; 8 patients, stage 3; 2 patients. Tumor staging was has yet to be determined for 3 patients. Although the difference in cancer stage at time of diagnosis between insured and non-insured patients was insignificant, the time span between diagnosis and treatment of patients with insurance averaged 29.9 days, while the non-insured patients averaged 78.6 days. CONCLUSIONS: From past studies we do know that long-term survival of women with breast cancer is dependent on the stage of the disease at the time of diagnosis. It is also been shown that breast cancer diagnosis at early stages of progression is low in the Hispanic population compared to the white non-Hispanic population. We hope to identify further factors that are contributing to this difference.

UR - http://www.scopus.com/inward/record.url?scp=33750102633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750102633&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750102633

VL - 47

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 2

ER -